Msd announced today that the European Commission has approved pembrolizumab in combination with enfortumab vedotin, as neoadjuvant treatment and subsequently, after radical cystectomy, as adjuvant ...
Approximately 360 million euros of investments in the three ports of the Network, already completed works and new interventions to be planned through an integrated vision of infrastructure, energy and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results